Dr. Stephen Michael Keen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Shipwash Dr, Garner, NC 27529 Phone: 919-662-7600 Fax: 919-662-7675 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that data from a comprehensive Phase I multi-dose program with its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation today at the Endocrine Society Annual Meeting in Boston, June 4-7, 2011.
Upsher-Smith Laboratories, Inc. announced today the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).
Agriculture ministers from Latin America and the Caribbean came together Tuesday to discuss strategies aimed at eradicating hunger and poverty by 2025, Xinhua/People's Daily Online reports.
Shire plc announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. and the subsequent acquisition of NPS Pharma.
› Verified 9 days ago